- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02948621
Endoscopic Sleeve Gastroplasty (Endosleeve)
The endoscopic sleeve gastroplasty allows stomach size reduction through an endoluminal suture approach without any incision. It could reduce the complications associated with current surgical techniques while obtaining the target gastric restriction, weight loss, comorbidities and quality of life improvement.
The primary objective of this study is to assess weight loss after endoscopic sleeve gastroplasty in patients with morbid obesity.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Gastric restriction is one of the fundamental principles of gastric bypass and gastric banding. Nowadays, practitioners have the possibility to reduce stomach size by merging tissues through an endoscopic endoluminal suture approach without any incision. This could reduce the complications associated with current surgical techniques while obtaining the target gastric restriction, weight loss, comorbidities and quality of life improvement.
The primary objective of this study is to assess weight loss after endoscopic sleeve gastroplasty in patients with morbid obesity according to the technique described in the literature: reduction of the gastric pouch into a sleeve structure by modification of the stomach greater curvature thanks to a plication.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Contact
- Name: Silvana Perretta, MD, PhD
- Phone Number: + 33 (0)3 69 55 13 55
- Email: silvana.perretta@chru-strasbourg.fr
Study Contact Backup
- Name: Michel Vix, MD
- Phone Number: + 33 (0)3 69 55 05 49
- Email: michel.vix@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France, 67000
- Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil de Strasbourg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient > 18 years old and < 60 years old
- Patient with morbid obesity for at least 2 years
- Patient who failed medical and diet treatment of obesity
- Patient with no contraindication to anesthesia
- Patient able to understand the study and to provide informed consent.
Exclusion Criteria:
- Patient with inflammatory, tumoral or bad quality tissues at endoscopy
- Patient with a history of gastro-intestinal inflammatory disease, stenosis or intestinal adhesions, kidney or liver failure, chronic pancreatic disease
- Patient with a history and/or signs and/or symptoms of gastroduodenal ulcerous disease and/or progressive gastroduodenal ulcerous disease
- Patient with an oesophageal pathology as Zenker's diverticulum, peptic oesophagitis stage 3-4, oesophageal stenosis, Barrett syndrome, oesophageal cancer, dysphagia, achalasia
- Patient with previous bariatric, gastric or oesophageal surgery, intestinal obstruction, portal hypertension, gastro-intestinal tumors, oesophageal or gastric varices, gastroparesis
- Patient with a severe coagulopathy (prothrombin time > 3 seconds or thrombocytic count < 50 000/mm3) or treated with heparin, coumadin, warfarin or any other anticoagulants and drugs preventing coagulation or platelet aggregation, except aspirin and nonsteroidal anti-inflammatory drugs
- Pregnancy, breastfeeding or woman without contraception
- Patient with a congestive heart failure, arrhythmia or unstable coronary heart disease
- Patient using or having used diet drugs within the last 30 days or intending to use them during study follow-up
- Patient under drug treatment within the last 3 months known to induce weight gain
- Patient with eating disorders or uncontrolled, poorly controlled or suspected psychiatric disease
- Patient in a poor condition according to investigator
- Patient in exclusion period (determined by a previous study or in progress)
- Patient with significative weight loss between date of enrollment in the study and date of procedure
- Patient with a systemic infection the day of procedure.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Endoscopic sleeve gastroplasty
Endoscopic sleeve gastroplasty is performed using a CE marked endoscopic suture device (Overstitch, Apollo Endosurgery, Austin, Tx.
USA).
Continuous stitches are placed to create a sleeve-shaped gastric path of 2 cm diameter to reduce stomach volume from the proximal antrum to the oeso-gastric junction.
|
Endoscopic sleeve gastroplasty is performed using a CE marked endoscopic suture device (Overstitch, Apollo Endosurgery, Austin, Tx.
USA).
Continuous stitches are placed to create a sleeve-shaped gastric path of 2 cm diameter to reduce stomach volume from the proximal antrum to the oeso-gastric junction.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Weight loss
Time Frame: 7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
Excess weight loss
Time Frame: 7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
Body mass index variation
Time Frame: 7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Procedure reproducibility
Time Frame: 7 days, 1 - 3 - 6 - 9 and 12 months after procedure
|
Absence of adverse event within 12 months after procedure.
|
7 days, 1 - 3 - 6 - 9 and 12 months after procedure
|
Comorbidities improvement
Time Frame: 7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
Improvement of hyperlipidemia, arterial hypertension, diabetes, reflux, osteoarticular disorders compared with preoperative data.
|
7 days, 1 - 3 - 6 - 9 - 12 - 18 and 24 months after procedure
|
Quality of life improvement
Time Frame: 3 - 12 - 18 and 24 months after procedure
|
Improvement of quality of life assessed by Moorehead-Ardelt Quality of life II questionnaire and Gastro-intestinal Quality of Life Index questionnaire.
|
3 - 12 - 18 and 24 months after procedure
|
Modification in the feeling of satiety
Time Frame: 1 - 3 - 6 - 12 - 18 and 24 months after procedure
|
Satiety assessed by Three Factors Eating Questionnaire - R18.
|
1 - 3 - 6 - 12 - 18 and 24 months after procedure
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Silvana Perretta, MD, PhD, Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil de Strasbourg
- Principal Investigator: Michel Vix, MD, Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil de Strasbourg
Publications and helpful links
General Publications
- Lopez-Nava G, Galvao MP, da Bautista-Castano I, Jimenez A, De Grado T, Fernandez-Corbelle JP. Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy. 2015 May;47(5):449-52. doi: 10.1055/s-0034-1390766. Epub 2014 Nov 7.
- Lopez-Nava G, Galvao MP, Bautista-Castano I, Jimenez-Banos A, Fernandez-Corbelle JP. Endoscopic Sleeve Gastroplasty: How I Do It? Obes Surg. 2015 Aug;25(8):1534-8. doi: 10.1007/s11695-015-1714-7.
- Lopez-Nava G, Galvao M, Bautista-Castano I, Fernandez-Corbelle JP, Trell M. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int Open. 2016 Feb;4(2):E222-7. doi: 10.1055/s-0041-110771. Epub 2016 Jan 15.
- Sharaiha RZ, Kedia P, Kumta N, DeFilippis EM, Gaidhane M, Shukla A, Aronne LJ, Kahaleh M. Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy. 2015 Feb;47(2):164-6. doi: 10.1055/s-0034-1390773. Epub 2014 Nov 7.
- Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc. 2013 Sep;78(3):530-5. doi: 10.1016/j.gie.2013.04.197. Epub 2013 May 24.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-001-OBS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Morbid Obesity
-
ClinTrio Ltd.UnknownMorbid Obesity Requiring Bariatric SurgeryBelgium, Germany, Portugal, Austria, Netherlands, Poland, Saudi Arabia
-
Centre Hospitalier Universitaire de NiceCompletedMorbid Obesity D009765France
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Hospices Civils de LyonCentre de Recherche en Nutrition Humaine Rhone-Alpe; Institut National de Recherche... and other collaboratorsRecruiting
-
Endolumik, IncWest Virginia UniversityNot yet recruitingMorbid ObesityUnited States
-
Rijnstate HospitalRecruiting
-
Laval UniversityCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie...Recruiting
-
University of WashingtonUnited States Department of DefenseWithdrawn
-
Helsinki University Central HospitalActive, not recruiting
-
IHU StrasbourgWithdrawnMorbid Obesity
Clinical Trials on Endoscopic sleeve gastroplasty
-
Radboud University Medical CenterEndotools TherapeuticsNot yet recruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingQuality of Life | Obesity | Microbiota | Endoscopic Sleeve Gastroplasty | Gastric Motility | Gastric HormonesItaly
-
Hvidovre University HospitalWithdrawnGlucose Metabolism Disorders | Laparoscopic Sleeve Gastrectomy | Endoscopic Sleeve Gastroplasty | Gut HormonesDenmark
-
King Saud UniversityKing Saud Medical CityCompletedObesity | Laparoscopic Sleeve Gastrectomy | Endoscopic Sleeve GastroplastySaudi Arabia
-
King Saud UniversityNew You Medical CenterCompleted
-
Grupo Hospital de MadridUnknown
-
Brigham and Women's HospitalEndo Tools Therapeutics S.A.Not yet recruitingObesity | Obesity, Morbid | Weight, Body | Metabolic DiseaseUnited States
-
Erasme University HospitalEndo Tools Therapeutics S.A.CompletedSleep Apnea Syndromes | Overweight and ObesityBelgium
-
Weill Medical College of Cornell UniversityCompleted
-
True You Weight LossErbe Elektromedizin GmbH; Erbe USA IncorporatedActive, not recruiting